ClinicalTrials.gg
CompletedNCT07944612Updated Nov 18, 2026

Fentanyl Versus Remifentanil for Anesthesia Induction in Pediatric Strabismus Surgery

A Phase 4 interventional study of Fentanyl and Remifentanil in Strabismus, sponsored by Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong. Completed at 1 site in China. Open to participants aged 3 Years to 14 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong · Phase 4, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jun 2026, registered Nov 2026).
Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
3 Years to 14 Years
Sex
All
01

Study summary

Strabismus surgery is a common procedure in children. The choice of opioid medication during anesthesia induction may influence early postoperative recovery, including the time needed for airway device removal, pain-related behavior, and adverse events.

This single-center, randomized, parallel-group clinical trial compared fentanyl and remifentanil administered intravenously during anesthesia induction in 100 children aged 3-14 years undergoing strabismus surgery. Participants were assigned to receive either fentanyl or remifentanil before insertion of a laryngeal mask airway. Both groups received the same intravenous anesthesia maintenance regimen.

The primary outcome was the time from completion of surgery to removal of the laryngeal mask airway. Secondary outcomes included recovery time, sedation-agitation scores, pain-related behavior, perioperative hemodynamic measurements, and adverse events.

The study aimed to evaluate whether the choice of opioid during anesthesia induction was associated with differences in early postoperative recovery.

02

Conditions studied

  • Strabismus

Browse trials for

Keywords

  • Pediatric Anesthesia
  • Fentanyl
  • Remifentanil
  • Postoperative Recovery
03

In context

Strabismus

143 studies on the registry are indexed under Strabismus; 31 are open to participants now.

This study's enrollment of 100 is above the median of 60 across 83 interventional studies indexed under Strabismus.

Browse Strabismus studies →

Lead sponsor

Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Children aged 3-14 years.
  2. Scheduled for elective strabismus correction surgery under general anesthesia.
  3. (ASA) physical status I or II.
  4. Written provided by a parent or legal guardian.

Exclusion criteria

Exclusion Criteria:

  1. History of allergy.
  2. Upper respiratory tract infection within one week before surgery.
  3. Body weight more than 30% above the age-specific reference weight.
  4. Parent or legal guardian declined participation.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Phase 4
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (actual)

Study arms

  • Active comparator
    Fentanyl Group

    Participants received fentanyl 2 mcg/kg as a single intravenous bolus at anesthesia induction before laryngeal mask airway insertion. Both groups received the same intravenous anesthesia maintenance regimen.

    Drug: Fentanyl

  • Experimental
    Remifentanil Group

    Participants received remifentanil 2 mcg/kg as a single intravenous bolus at anesthesia induction before laryngeal mask airway insertion. Both groups received the same intravenous anesthesia maintenance regimen.

    Drug: Remifentanil

Interventions

  • Fentanyl 2 mcg/kg was administered as a single intravenous bolus during anesthesia induction before laryngeal mask airway insertion.

  • Remifentanil 2 mcg/kg was administered as a single intravenous bolus during anesthesia induction before laryngeal mask airway insertion.

06

What researchers measure

Primary outcomes

  1. Time From End of Surgery to Laryngeal Mask Airway Removal

    Time in minutes from the documented end of surgery to removal of the laryngeal mask airway (LMA).

    Time frame: From completion of surgery until laryngeal mask airway removal, assessed up to 30 minutes after surgery completion.

Secondary outcomes

  1. Time From LMA Removal to PACU Discharge

    Time in minutes from removal of the laryngeal mask airway to discharge from the post-anesthesia care unit (PACU).

    Time frame: From laryngeal mask airway removal to post-anesthesia care unit discharge, assessed up to 40 minutes after airway removal.

  2. Riker Sedation-Agitation Scale Score

    Sedation and agitation assessed using the Riker Sedation-Agitation Scale at T4. Scores range from 1 to 7; lower scores indicate greater sedation, a score of 4 indicates a calm and cooperative state, and higher scores indicate greater agitation.

    Time frame: On the day of surgery, immediately before discharge from the post-anesthesia care unit, within 1 hour after airway removal.

  3. FLACC Pain Score

    Pain-related behavior assessed using the Face, Legs, Activity, Cry, and Consolability (FLACC) scale. Total scores range from 0 to 10, with higher scores indicating more pain-related behaviors.

    Time frame: On the day of surgery, immediately before discharge from the post-anesthesia care unit, within 1 hour after laryngeal mask airway removal.

  4. Perioperative Systolic Blood Pressure

    Systolic blood pressure in mmHg, recorded automatically by the patient monitor at five perioperative time points.

    Time frame: On the day of surgery, from before anesthesia induction through recovery unit discharge, up to 2 hours.

  5. Perioperative Heart Rate

    Heart rate in beats per minute, recorded automatically by the patient monitor at five perioperative time points.

    Time frame: On the day of surgery, from before anesthesia induction through recovery unit discharge, up to 2 hours.

  6. Participants With Adverse Events Within 30 Minutes After LMA Removal

    Number of participants with one or more recorded adverse events, including respiratory depression, nausea, vomiting, somnolence, pruritus, or agitation.

    Time frame: From airway removal through 30 minutes after airway removal, on the day of surgery.

  7. Participants With Adverse Events Within 24 Hours After Surgery

    Number of participants with one or more recorded adverse events during the 24-hour postoperative observation period.

    Time frame: From surgery completion through 24 hours after surgery.

07

Study locations

1 site
  • Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Dongxia North Road (Guangsha New Town), Shantou, Guangdong, China
    Shantou, Guangdong 515041, China
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the study involves pediatric patients and is subject to institutional privacy and data governance restrictions.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2026 to primary completion in Sep 2026, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 18, 2026
StartActual
Jun 20, 2026
Primary completionActual
Sep 21, 2026
CompletionActual
Sep 22, 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07944612
Lead sponsor
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong
Responsible party
Laiwen Lv (Principal Investigator, Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong) — Principal investigator
First posted
Nov 18, 2026
Start date
Jun 20, 2026
Primary completion
Sep 21, 2026
Completion
Sep 22, 2026
Last update
Nov 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Remifentanil

Start the discussion